Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 11, 1997, Pages 931-942

  Bostick, Roberd M ^a   Fosdick, Lisa ^b   Lillemoe, Tamera J ^c   Overn, Paula ^c   Wood, James R ^d   Grambsch, Patricia ^b   Elmer, Patricia ^b   Potter, John D ^e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ABBOTT NORTHWESTERN HOSPITAL   (United States)

^d Digestive Healthcare PA   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL PROLIFERATION; COLORECTAL CARCINOMA; DATA ANALYSIS; DIAGNOSTIC ACCURACY; EPIDEMIOLOGICAL DATA; HUMAN; LABELING INDEX; PRIORITY JOURNAL; RELIABILITY; SIGMOIDOSCOPY; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; BIOPSY; BROMODEOXYURIDINE; CELL DIVISION; COLON; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECTUM; S PHASE;

EID: 0030726967     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics, 1994. CA Cancer J. Clin., 44: 7-26, 1994.
2. Potter, J. D., Slattery, M. L., Bostick, R. M., and Gapstur, S. M. Colon cancer: a review of the epidemiology. Epidemiol. Rev., 15: 499-545, 1993.
3. Schatzkin, A., Schiffman, M., and Lanza, E. Research priorities in large bowel cancer prevention. Semin. Oncol., 17: 425-437, 1990.
4. Lipkin, M. Biomarkers of increased susceptibility to gastrointestinal cancer. Gastroenterology, 92: 1083-1086, 1987.
5. Lipkin, M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in humans. Cancer Res., 48: 235-245, 1988.
6. Lee, J., Lippman, S., Hong, W., Ro, J., Kim, S., Lotan, R., and Hittelman, W. Determination of biomarkers for intermediate end points in chemoprevention trials. Cancer-Res., 52 (Suppl.): 2707-2710, 1992.